AMIFOSTINE Drug Patent Profile
✉ Email this page to a colleague
When do Amifostine patents expire, and when can generic versions of Amifostine launch?
Amifostine is a drug marketed by Eugia Pharma Speclts and Sun Pharm and is included in two NDAs.
The generic ingredient in AMIFOSTINE is amifostine. There are six drug master file entries for this compound. Additional details are available on the amifostine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMIFOSTINE?
- What are the global sales for AMIFOSTINE?
- What is Average Wholesale Price for AMIFOSTINE?
Summary for AMIFOSTINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 86 |
| Patent Applications: | 5,022 |
| Drug Prices: | Drug price information for AMIFOSTINE |
| DailyMed Link: | AMIFOSTINE at DailyMed |
Recent Clinical Trials for AMIFOSTINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institut du Cancer de Montpellier - Val d'Aurelle | Phase 3 |
| Tata Memorial Centre | Phase 3 |
| British Columbia Cancer Agency | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for AMIFOSTINE
Anatomical Therapeutic Chemical (ATC) Classes for AMIFOSTINE
Paragraph IV (Patent) Challenges for AMIFOSTINE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ETHYOL | For Injection | amifostine | 500 mg/vial | 020221 | 1 | 2004-04-16 |
US Patents and Regulatory Information for AMIFOSTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma Speclts | AMIFOSTINE | amifostine | INJECTABLE;INJECTION | 204363-001 | Jul 17, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm | AMIFOSTINE | amifostine | INJECTABLE;INJECTION | 077126-001 | Mar 14, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
